title: Neuromodulation Treatments for Geriatric Mood and Cognitive Disorders.
abstract: There is increasing evidence for the efficacy of neuromodulation in the treatment of resistant mood disorders and emerging data supporting the use of neuromodulation in cognitive disorders. A significant minority of depressed elders do not respond to pharmacotherapy and/or psychotherapy. This has led clinicians to recommend the increasing use of electroconvulsive therapy (ECT) in the treatment of medication-resistant or life-threatening geriatric depression. Multiple studies have supported the safety and efficacy of ECT in the elderly, yet ECT is associated with side effects including cardiovascular and cognitive side effects. Neuromodulation therapies have the potential for providing effective treatment for treatment-resistant older adults with reduced side effects and this review will outline the risks and benefits of neuromodulation treatment in geriatric psychiatry. There is also emerging evidence of the efficacy of neuromodulation devices in the treatment of cognitive disorders. Pharmacotherapy has been largely ineffective in changing the course of neurodegenerative diseases causing dementia and other treatments are clearly needed. This review will outline the available evidence for neuromodulation in the treatment of mood and cognitive disorders in the elderly.
authors.affiliation: Department of Psychiatry and Behavioral Sciences, Emory University, Atlanta, GA, USA. Electronic address: wmcdona@emory.edu.
authors.forename: William M
authors.initials: WM
authors.lastname: McDonald
mesh_terms: D000368:Aged; D003072:Cognition Disorders / Q000628:therapy*; D003295:Convulsive Therapy / Q000009:adverse effects / Q000379:methods; D046690:Deep Brain Stimulation / Q000009:adverse effects / Q000379:methods; D004565:Electroconvulsive Therapy / Q000009:adverse effects / Q000379:methods; D006801:Humans; D019964:Mood Disorders / Q000628:therapy*; D050781:Transcranial Magnetic Stimulation / Q000009:adverse effects / Q000379:methods; D055536:Vagus Nerve Stimulation / Q000009:adverse effects / Q000379:methods
keywords: DBS; Depression; ECT; TMS; dementia; neuromodulation; tDCS